Telekin suppresses human hepatocellular carcinoma cells in vitro by inducing G2/M phase arrest via the p38 MAPK signaling pathway. [electronic resource]
Producer: 20150410Description: 1311-22 p. digitalISSN:- 1745-7254
- Apoptosis -- drug effects
- CDC2 Protein Kinase
- Carcinoma, Hepatocellular -- drug therapy
- Cell Cycle Checkpoints -- drug effects
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cell Survival -- drug effects
- Cyclin B1 -- metabolism
- Cyclin-Dependent Kinases -- metabolism
- G2 Phase Cell Cycle Checkpoints -- drug effects
- Hep G2 Cells
- Humans
- Intracellular Signaling Peptides and Proteins -- metabolism
- Liver Neoplasms -- drug therapy
- Protein Serine-Threonine Kinases -- metabolism
- Reactive Oxygen Species -- metabolism
- Sesquiterpenes, Eudesmane -- pharmacology
- Signal Transduction -- drug effects
- cdc25 Phosphatases -- metabolism
- p38 Mitogen-Activated Protein Kinases -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.